Chinese biopharmaceutical company (01177.HK) spent 10.32 million Hong Kong dollars on April 30 to repurchase 1.85 million shares.

The Zhitong Finance and Economics APP reported that China Biopharmaceuticals (01177.HK) announced that it will spend 1003.2 million Hong Kong dollars to repurchase 1.85 million shares on April 30, 2026.